Market Research Reports Global Hirudin Market Size 2017

Global Hirudin Market Attractiveness, Competitive
Landscape and Forecasts
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in
the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood
anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
Scope of the Report:
This report focuses on the Hirudin in Global market, especially in North America,
Europe and Asia-Pacific, South America, Middle East and Africa. This report
categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Browse Complete Report on Global Hirudin Market in 2017
Market Segment by Type, covers
Natural Hirudin
Recombinant Hirudin
Market Segment by Applications, can be divided into
Thrombosis Disease
Tumor Disease
Others
There are 15 Chapters to deeply display the global Hirudin market.
Chapter 1, to describe Hirudin Introduction, product scope, market overview, market
opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hirudin, with sales, revenue, and
price of Hirudin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with
sales, revenue and market share in 2016 and 2017;